Skip to Main Content

Paper Details

A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Urol Oncol
12
2020
BC, FOXE1, GATA4, NID2, RUNX3, TWIST1, Urinary cell, Urinary cell sediment DNA, bladder cancer, cancer, differentially methylated genes, high, high-grade BC, methylated genes, methylation biomarker, methylation markers, patients
Author NameAffiliation
Ekaterina Olkhov-MitselLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Cynthia KukPrincess Margaret Cancer Centre, University Health Network, Mount Sinai Hospital
Peter J WildUniversity Hospital Zurich, University of Zurich, Switzerland Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt
Tristan JuvetPrincess Margaret Cancer Centre, University Health Network
Theodorus H van der KwastUniversity of Toronto, University Health Network
Antonio FinelliPrincess Margaret Cancer Centre, University Health Network
Girish S KulkarniPrincess Margaret Cancer Centre, University Health Network
Neil E FleshnerPrincess Margaret Cancer Centre, University Health Network
Bharati BapatLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Alexandre R ZlottaLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Princess Margaret Cancer Centre, University Health Network
  • 1 - 10

Datasets

Release 1.2